AMPA Receptor 3 (GluA 3) Antibody

Skip to product information
1 of 1

Selleck Chemicals

SKU:F1270-20UL

Regular price €139,00 EUR
Regular price Sale price €139,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

GRIA3 is a target of interest in many antibody-based workflows. In the mammalian brain, AMPA-type glutamate receptors (AMPARs), composed of GluA1-GluA4 subunits, are crucial for excitatory synaptic transmission and various forms of synaptic plasticity. GluA1 and GluA2 are predominant in the hippocampus and cortex, respectively, contributing to plasticity and calcium permeability. GluA3, enriched at synapses and involved in synaptic maintenance and memory, along with GluA4, expressed early for synapse maturation, highlight the diverse functional roles of these subunits. Depending on the literature source, GRIA3 may also be discussed as AMPA Receptor 3 (GluA 3).

Reported cellular context includes cell membrane, membrane, postsynaptic cell membrane, and synapse, which can matter when signal is compared across treatments or changing cell states. Following GRIA3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

GRIA3 is commonly interpreted in the context of neuroscience and developmental biology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, membrane, and postsynaptic cell membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cell membrane, membrane, and postsynaptic cell membrane across matched conditions
  • compartment-specific patterns relevant to neuronal polarity, transport, or synaptic context
  • stage-dependent patterns during differentiation, morphogenesis, or lineage commitment
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for GRIA3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in GRIA3 reflect biology rather than handling. When interpreting GRIA3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep GRIA3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
GRIA3
Research Area:
Developmental Biology • Neuroscience
Application:
IP • WB
Reactivity:
Human • Mouse • Rat
Specificity:
AMPA Receptor 3 (GluA 3) Antibody [J1J21] detects endogenous levels of total GluA 3 protein. The antibody is not predicted to detect other AMPA receptor subunits (e.g. GluA 1, GluA 2 or GluA 4) based on sequence homology of the antigen.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
J1J21
UniProt:
P42263
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.